Form D Explorer

Form D — ESTRIGENIX THERAPEUTICS, INC.

0002141466-26-000001 · filed Jul 27, 2026

Offering

Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $2,000,000
Total sold: $1,000,000
Minimum investment: $150,000
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: ESTRIGENIX THERAPEUTICS, INC.
CIK: 2141466
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: —
Address: 1225 DISCOVERY PKWY
WAUWATOSA, WI 53226
Phone: (262) 409-1484

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Daniel Sem · Executive Officer

Wauwatosa, WI Find on LinkedIn ↗
William Donaldson · Executive Officer

Wauwatosa, WI Find on LinkedIn ↗
Karyn Frick · Executive Officer

Wauwatosa, WI Find on LinkedIn ↗
Patricia Scheller · Director

Wauwatosa, WI Find on LinkedIn ↗
Victoria Zellmer · Executive Officer

Wauwatosa, WI Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗